The recommendation is to use the adjuvanted vaccine because they usually respond very poorly. But those data are not available yet. We are moving forward here, but there are still these special groups that we need to study. Do we need one or two doses of the vaccine? It's an ongoing dilemma on how to deal with those people, but I think the recommendation is to use two doses of the adjuvanted vaccine.
On October 26th, 2009. See this statement in context.